trial
as of 2026-07-01Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study
NCTId NCT00708396
at a glance
Phase 4 · Unknown
Enrollment 20 (estimated)
Sponsored by BeerYaakov Mental Health Center
Primary completion 2010-07
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Unknown
Enrollment
20 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2008-07
Primary completion
2010-07
Eligibility
ALL · 18 Years
Interventions & indications
Drugs
Indications
Sponsors
BeerYaakov Mental Health CenterLead Sponsor
Investigators
1
Rafael Octavio Stryjer, MDPrincipal Investigator
Sites
1 total
Beer-Yaacov, Israel
Facts & assertions
4 sourced
Enrollment
20
Phase
PHASE4
Primary Completion Date
2010-07
Status
UNKNOWN
relationships
The graph out of here
drug
drug
lead_sponsor
indication
investigator